Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Intravascular Surgery Devices Market size is expected to expand at significant growth rate during the forecast period i.e., between 2025-2037.
The growth of the market can be attributed to the increasing cases of vascular diseases which require surgery, along with rising healthcare expenditure globally. The growing disposable income of individuals across the globe, combined with presence of favorable reimbursement and health insurance policies, are estimated to drive the market growth. Moreover, a large share of heart patients is opting for surgery, owing to the up-surge in health awareness. Along with rising awareness amongst public, increasing initiatives by governments around the globe, are anticipated to boost the market growth. On the other hand, increasing cases of cardiovascular diseases, due to poor lifestyle, including, lack of activities and consumption of fast food, is foreseen to provide growth opportunities for the market. According to a report by the World Health Organization (WHO), CVDs are responsible for over 17.9 million lives each year, making it the leading cause of death worldwide.
Moreover, cardiovascular diseases are the primary cause of premature death currently, out of which, over one third deaths occur below the age of 70 years, as per WHO data. Surgeries are the best course of treatment in case of stroke or heart attack, as the results are instant. Moreover, various technological advancements in the medical sector, have improved the scope and reach of surgeries. Such factors are estimated to strengthen the market growth.

Intravascular Surgery Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Increasing Incidences of Cardiovascular Diseases
- Growing Expenditure for Healthcare by Government Authorities as well as Public
Challenges
- Lesser Number of Surgeons in Low-income Countries
- Circulation of Generic Equipment in the Market
Base Year |
2024 |
Forecast Year |
2025-2037 |
|
|
|
|
|
|
Regional Scope |
|
Intravascular Surgery Devices Segmentation
The market is segmented by end-user into hospital, ambulatory surgical centers, and others, out of which, the ambulatory surgical centers segment is anticipated to hold the largest share in the global intravascular surgery devices market over the forecast period as ambulatory surgical centers are specifically equipped for performing surgeries, generating a significant market for surgical devices and equipment.
Our in-depth analysis of the global intravascular surgery devices market includes the following segments:
By Device Type |
|
By End-User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportIntravascular Surgery Devices Industry - Regional Synopsis
North America Market Analysis
North America industry is likely to account for largest revenue share by 2037, impelled by rising prevalence of lifestyle diseases, along with unhealthy lifestyle prevalent amongst the population. North America industry is predicted to account for largest revenue share by 2036, impelled by rising prevalence of lifestyle diseases, along with unhealthy lifestyle prevalent amongst the population. Moreover, higher healthcare expenditure in the region, and presence of patient-friendly reimbursement policies, are estimated to boost the market growth. According to the World Bank, 16.885% of the GDP of United States was spent for healthcare in 2018.
APAC Market Statistics
The market in the Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing awareness regarding healthcare amongst people, along with improving healthcare facilities in the region.


Companies Dominating the Intravascular Surgery Devices Landscape
- Eli Lilly and Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Akili Interactive Labs, Inc.
- Koninklijke Philips N.V.
- WellDoc, Inc.
- Noom, Inc.
- Pear Therapeutics, Inc.
- Teladoc Health, Inc.
- Click Therapeutics, Inc.
- Ayogo Health Inc.
In the News
- September, 2021: ViiV Healthcare, collectively owned by GlaxoSmithKline plc, Pfizer Inc. and Shionogi announced approval of the U.S. Food and Drug Administration (FDA) for cabotegravir as an antiviral drug.
- February, 2021: Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote cardiac diagnostics and monitoring, to support cardiac surgeries and treatments.
Author Credits: Radhika Pawar
- Report ID: 3709
- Published Date: Dec 24, 2024
- Report Format: PDF, PPT